Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harte Hanks (HHS) Change in Accured Expenses (2016 - 2025)

Harte Hanks (HHS) has disclosed Change in Accured Expenses for 16 consecutive years, with $2.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Change in Accured Expenses rose 368.69% to $2.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$878000.0, a 9.2% decrease, with the full-year FY2024 number at -$4.1 million, down 87.55% from a year prior.
  • Change in Accured Expenses was $2.3 million for Q3 2025 at Harte Hanks, up from -$529000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $2.3 million in Q3 2025 to a low of -$3.8 million in Q1 2023.
  • A 5-year average of -$367684.2 and a median of -$131000.0 in 2021 define the central range for Change in Accured Expenses.
  • Peak YoY movement for Change in Accured Expenses: plummeted 4544.74% in 2022, then soared 882.64% in 2023.
  • Harte Hanks' Change in Accured Expenses stood at -$131000.0 in 2021, then surged by 775.57% to $885000.0 in 2022, then skyrocketed by 54.12% to $1.4 million in 2023, then tumbled by 243.55% to -$2.0 million in 2024, then soared by 217.47% to $2.3 million in 2025.
  • Per Business Quant, the three most recent readings for HHS's Change in Accured Expenses are $2.3 million (Q3 2025), -$529000.0 (Q2 2025), and -$691000.0 (Q1 2025).